- Who is Sysmex?
- Life Science
- Flow cytometry
- Solution Provision
- Knowledge Centre
- Clinic & Laboratory
Select your local website
Company news articles found here detail internal and external events that may be interesting for all stakeholders. Whether it’s CSR activities, product launches, collaborations or reports on events, you can stay up-to-date on the latest Sysmex news.
2020/10/09 | Norderstedt, Germany
Sysmex Europe is celebrating 40 years of diagnostic advancement and growth
Sysmex Europe GmbH celebrates 40 years of business in EMEA and looks forward to continuing lighting the way with diagnostics.
Updates & information on COVID-19
Sysmex launches next-generation fully automated blood coagulation analysers CN-6000 and CN-3000 in EMEA
Power in a new dimension for the haemostasis laboratory
Sysmex to Launch Novel Coronavirus (SARS-CoV-2) Antibody Lab Assay Service and Antibody Measurement Reagents (for Research)
Using the HISCL™-5000/HISCL™-800 Fully Automated Immunoassay Systems to Realize SARS-CoV-2 Antibody Detection
The City of Kobe, Kobe City Medical Center General Hospital, and Sysmex Corporation Working to Launch from Kobe the Clinical Implementation of a New Test for the Novel Coronavirus
Collaborating with Medical Institutions of the Foundation for Biomedical Research and Innovation at Kobe to Strengthen Measures Allowing Early-Stage Diagnosis and Prediction of Severity
The National Cancer Center, the National Center for Global Health and Medicine, and Sysmex Corporation Evaluatea SARS-CoV-2 Antibody Test with Support from the Japan Health Research Promotion Bureau
Performance Report onan Antibody Detection Reagent Using Clinical Specimens
Sysmex Obtains First Marketing Approval in Japan for the Automated Hematology Analyzer XN-31 as a Class III Specially Controlled Medical Device to Diagnose Malaria
For Use as a Measure against Imported Infectious Diseases in Japan and Accelerating its Introduction to the Asian and African Markets
OSNA label extension for cervical, endometrial and prostate cancer
Sysmex Obtains First Marketing Approval in Japan for the Novel Coronavirus Nucleic Acid Detection Kits (RT-PCR Method)
Aiming for early introduction of test kits forin vitrodiagnostic medical devicesin medical institutions
-Japanese market only-
-Japanese market only-
Magseed® magnetic marker approved for any soft tissue and long-term implantation across Europe
Hitado GmbH becomes Nexus IB10 distributor for sphingotec in Germany and Switzerland
Sysmex gives back – supporting social development together
OSNA for lung cancer – the newest addition to our oncology portfolio
Sysmex Europe GmbH wins Silver Technology Award from the 2019 Learning In Practice Awards Program by Chief Learning Officer magazine.
Sysmex Europe GmbH wins the Silver Award for ‘Best Customer Training Program’ from the 2019 Brandon Hall Group Excellence in Learning Awards
Hamburg leaders visited Sysmex Corporation in Kobe
A welcome addition to our portfolio: Sentinel’s SENTiFOB® analyser with new cap-piercing function, ideal for low-middle throughput, for the detection of faecal occult blood using FOBGold® reagents
Sysmex Europe GmbH was awarded as ‘Top Employer SME 2019’ and ranked 8th in the category ‘Electronics and Electrical Engineering, Medical Devices’
Sysmex Europe GmbH organises a blood donation and sport event on 3 December
Congratulations to our CEO Hisashi Ietsugu!
Sysmex Middle East in Medlab exhibition 5-8 February 2018 in Dubai- UAE
Sysmex is creating new opportunities, involving more and more stakeholders, and increasingly getting to the root of the core issues our healthcare clients face.